1490MO CDK4/6 inhibition in locally advanced/metastatic chordoma (NCT PMO-1601)
M-V. Teleanu, Christoph E. Heilig, Rainer Hamacher, Sebastian Bauer, R. Mayer-Steinacker, Verena I. Gaidzik, Peter Horak, L-M. Lanz, T. Muskatewitz, H. Süsse, Angelika Freitag, M. von Hornung, L. Wacker, C. Von Kalle, T. Barth, Stefan Fröhling, Richard F. Schlenk
Topics & Concepts
MedicinePalbociclibChordomaCDKN2AClinical endpointProgressive diseaseInternal medicineOncologyResponse Evaluation Criteria in Solid TumorsSurgeryChemotherapyCancerClinical trialMetastatic breast cancerBreast cancerAdvanced Breast Cancer TherapiesCancer-related Molecular PathwaysMultiple Myeloma Research and Treatments